The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population

Annals of Oncology

Volumn 23, Issue 2, 2012, Pages 401-405

  Yun, S J ^a   Ha, Y S ^a   Chae, Y ^b   Kim, J S ^a   Kim, I Y ^c   Kim, W J ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

hOGG1; Prostatic neoplasms; Single nucleotide polymorphism

Indexed keywords

CYSTEINE; GENOMIC DNA; PEPTIDE NUCLEIC ACID; SERINE;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CODON; CONTROLLED STUDY; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GLEASON SCORE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN 8 OXOGUANINE GLYCOSYLASE 1 GENE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; WILD TYPE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84863023099     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr115     Document Type: Article

References (28)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
3. Damber JE, Aus G. Prostate cancer. Lancet 2008; 371: 1710-1721.
4. Lee J, Demissie K, Lu SE, Rhoads GG. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control 2007; 14: 78-85.
5. Dunn JE. Cancer epidemiology in populations of the United States-with emphasis on Hawaii and California-and Japan. Cancer Res 1975; 35: 3240-3245.
6. Shimizu H, Ross RK, Bernstein L et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 963-966.
7. Crawford ED. Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 2009; 73: S4-S10.
8. Kang TS, Jin SK, Lee JE et al. Comparison of genetic polymorphisms of the NAT2 gene between Korean and four other ethnic groups. J Clin Pharm Ther 2009; 34: 709-718.
9. Dianat SS, Margreiter M, Eckersberger E et al. Gene polymorphisms and prostate cancer: the evidence. BJU Int 2009; 104: 1560-1572.
10. Nakayama T, Kaneko M, Kodama M, Nagata C. Cigarette smoke induces DNA single-strand breaks in human cells. Nature 1985; 314: 462-464.
11. Cheng KC, Cahill DS, Kasai H et al. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 1992; 267: 166-172.
12. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 2000; 377: 1-8.
13. Kohno T, Shinmura K, Tosaka M et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998; 16: 3219-3225.
14. Liu CJ, Hsia TC, Tsai RY et al. The joint effect of hOGG1 single nucleotide polymorphism and smoking habit on lung cancer in Taiwan. Anticancer Res 2010; 30: 4141-4145.
15. Narter KF, Ergen A, Agachan B et al. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res 2009; 29: 1389-1393.
16. Poplawski T, Arabski M, Kozirowska D et al. DNA damage and repair in gastric cancer-a correlation with the hOGG1 and RAD51 genes polymorphisms. Mutat Res 2006; 601: 83-91.
17. Wagenlehner FM, Elkahwaji JE, Algaba F et al. The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int 2007; 100: 733-737.
18. Xu J, Zheng SL, Turner A et al. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 2002; 62: 2253-2257.
19. Chen L, Elahi A, Pow-Sang J et al. Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol 2003; 170: 2471-2474.
20. Nock NL, Cicek MS, Li L et al. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis 2006; 27: 1842-1848.
21. Dhillon VS, Yeoh E, Fenech M. DNA repair gene polymorphisms and prostate cancer risk in South Australia-results of a pilot study. Urol Oncol 2009 Nov 12. [Epub ahead of print], doi:10.1016/j.urolonc.2009.08.013
22. Zhang J, Dhakal IB, Greene G et al. Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants. Urology 2010; 75: 779-785.
23. Li H, Hao X, Zhang W et al. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 1739-1745.
24. Kim EJ, Jeong P, Quan C et al. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 2005; 65: 70-75.
25. Arizono K, Osada Y, Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol 2008; 38: 186-191.
26. Tsukino H, Hanaoka T, Otani T et al. hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci 2004; 95: 977-983.
27. Pelucchi C, Bosetti C, Negri E et al. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 2006; 3: 327-340.
28. Chen CY, Shiesh SC, Wu SJ. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis. Clin Chem 2004; 50: 481-489.